Derek Meisner was Appointed as Senior Vice President and General Counsel at Genocea

Date of management change: October 01, 2018 

What Happened?

Cambridge, -based Genocea Appointed Derek Meisner as Senior Vice President and General Counsel

 

About the Company

Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS™, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.

 

About the Person

Derek Meisner is Senior Vice President and General Counsel at Genocea. Previously, Derek held various senior legal leadership roles in the industry.

 

Info Source

Press Release

 
 

Other IT executives who recently changed jobs as well: Millikin Michael, Stetson David, Insande Gael, Nemrow Anabel, Boxes Amy, Rabun Dana, Sedlack Paul, Cardiff David, Tinsley Nancy, Gray-Kemp Felice, Motola Niza

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.